Tag Archives: Access

Patent

WIPO’s New AI Translation Tool Fosters Access to Information on Patented Inventions


In a pioneering step towards facilitation of access to information on patented inventions, WIPO has developed a breakthrough tool, based on artificial intelligence, for instant high quality translation of patent documents. This tool, called WIPO Translate, can be used free of charge and is available through the WIPO’s PatentScope database that contains PCT applications as well as patent documents of participating national and regional patent offices. As we know, one of the objectives of granting patents is disclosure of inventions…


Read More »
Copyright Publication

Open Access IP Course Books


Case books and textbooks are expensive and often even unaffordable for students. What is appalling is where the money from these exorbitant rates go – not towards the publishing costs or author’s royalties but to the publishers who act as middlemen in this process.  Several of these published books are case books or statute books, and merely compile what is already available in the public domain. In recent years, the open access movement has gained more momentum, enabled by the…


Read More »
Copyright

Pretty Sexy Movies and Copyright Law: IP Juris-prurience (2)


  Late last week, we unleashed a new series titled “IP Juris-prurience” (or to put it more bluntly, “Sex and IP”!) Our first post revolved the famous Viagra Patent Case, where I highlighted the differential rulings on validity the world over. While the UK rejected the patent on grounds of obviousness, Canada did so on the ground of insufficient disclosure, castigating Pfizer for playing “hide and seek” with the public. Meanwhile China (which also rejected the patent on credible grounds) faced the…


Read More »
Uncategorized

DIPP refuses CL plea for Herceptin: Health ministry requests Govt to revoke patent in public interest.


  In a surprising move,DIPP has taken a decision to refuse grant of CL for anticancer biologic Trastuzumab/Herceptin as reported by Sidhartha of Times of India. Background: Earlier in Nov 2012 and again in March 2013 campaign for affordable trastuzumab (an association of patients and NGO’s) had urged the Govt to take appropriate measures to ensure affordability of Herceptin. Subsequently Trastuzumab was recommended for CL by the health ministry. Read our previous posts (here and here). However after several months…


Read More »

The trend of blocking URL’s on ISP’s continues in India?


Recently, Medianama reported that certain URL’s such as Uploaded.net, ul.to, stooorage.com and lookingglass.blog.co.uk have been blocked on certain ISP’s in India. These URL’s are those of file sharing sites, image hosting sites as well as a foreign blog on politics. These come in a long line of websites blocked on the orders of the DoT, such as the orders to ISP to block 78 URL’s in India as well as the April 2013 order to block websites such as Zegde and Care.org in…


Read More »
Uncategorized

India’s patent policy: Big Pharma’s grouse?


In a congressional hearing last week, Roy Waldron, Chief Intellectual Property (IP) counsel of American Pharma giant, Pfizer raised concerns over India’s “protectionist” IP regime. The Capitol Hill testimony can be accessed here.   Waldron alleged that since the advent of the product patent regime in 2005, India has continually defied trade rules and supported the domestic generic industry at the expense of innovators. On the other hand Indian generic industry has increased its US sales dramatically. To quote “Three…


Read More »
Uncategorized

Patents vs. Patients: Department of Pharmaceuticals issues draft policy on pricing of patented drugs


Earlier this week, the Department of pharmaceuticals (DOP) issued a draft proposal on price negotiation of patented drugs and has invited comments from stakeholders on the recommendations of the committee before the end of this month. This draft policy proposal couldn’t have come at a better time, especially since the IPAB decision on Bayer’s appeal against compulsory license(CL) issued for its Nexavar (First ever post TRIPS CL granted by India) is expected early next week.   The Parliamentary standing committee’s…


Read More »
Uncategorized

The ‘Global’ Fund being criticized


The Global Fund to fight AIDS, Tuberculosis and Malaria was created in 2002 in order to attract, manage and disburse resources to fight these three deadly diseases across the world. Since its inception, as reported, the Global Fund has supported more than 1,000 programs in 151 countries, providing AIDS treatment for 4.2 million people, anti-tuberculosis treatment for 9.7 million people and 310 million insecticide-treated nets for the prevention of malaria. It has also become the main multilateral funder in global…


Read More »
Patent

Guest Post: For whom is the Indian IPR Regime?


Aparajita Lath brings us her third submission to our SpicyIP Fellowship applicant series. Usually, when we’re discussing ‘access’ and IP, we’re referring to diffusion of innovation. In this post though, she points out that for most of our country, accessing the reigns of this system as an inventor is problematic as well. For who is the Indian Intellectual Property Right Regime? “I went through thirty-five stages. I began with the Queen upon the Throne. I ended with the Deputy Chaff-wax…


Read More »

Open Access: What is it about?


Aaron Swartz’s recent suicide has sparked discussion all over the internet, with much of it to do with his  strong belief in the moral imperative of sharing scholarship and making it accessible to all. There’s a certain strong raw attraction towards this idea, however, it’s practicality is far from a simple matter. It’s a rather complicated and nuanced question that needs more serious discussion along with the impassioned cries. I found myself in one of these discussions, (sparked by Shashank…


Read More »